These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1650 related articles for article (PubMed ID: 1728195)

  • 1. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
    Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
    Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell rich and histiocyte rich B cell lymphoma--a case report.
    Rajwanshi A; Banerjee AK; Chawla YK
    Indian J Pathol Microbiol; 1997 Jan; 40(1):85-9. PubMed ID: 9145621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management.
    Abramson JS
    Oncologist; 2006 Apr; 11(4):384-92. PubMed ID: 16614234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
    Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
    Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness.
    Krishnan J; Wallberg K; Frizzera G
    Am J Surg Pathol; 1994 May; 18(5):455-65. PubMed ID: 8172320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B-cell lymphoma and its variants.
    Dominis M; Dzebro S; Gasparov S; Pesut A; Kusec R
    Croat Med J; 2002 Oct; 43(5):535-40. PubMed ID: 12402391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow involvement in T-cell-rich B-cell lymphoma.
    Skinnider BF; Connors JM; Gascoyne RD
    Am J Clin Pathol; 1997 Nov; 108(5):570-8. PubMed ID: 9353097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features.
    Achten R; Verhoef G; Vanuytsel L; De Wolf-Peeters C
    Histopathology; 2002 Jan; 40(1):31-45. PubMed ID: 11903596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
    Huang Q; Wilczynski SP; Chang KL; Weiss LM
    Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
    Churchill HR; Roncador G; Warnke RA; Natkunam Y
    Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?
    Schmidt U; Metz KA; Leder LD
    Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
    Nguyen DT; Diamond LW; Hansmann ML; Fischer R
    Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.